You are here: Industry Insights > FDA

News List

O-drug Approved as First-line Immunotherapy for Gastric Cancer and What Other Domestic Counterparts to Expect PharmaSources/Yefenghong
May 08, 2021
O-drug is the first approved immunotherapy for first-line treatment of gastric cancer.
Top Bulk Deflazacort Powder Manufacturers in China PharmaSources.com
April 13, 2021
Deflazacort (C25H31NO6) is a glucocorticoid that works as an immunosuppressant and anti-inflammatory. The FDA (Food and Drug Administration) considers it a first-class medication approved in 2017. Generally, it is a corticosteroid prodrug that can ...
Biosimilars 2020: Low Approvals, but Significant Advances Neeta Ratanghayra
March 18, 2021
2020 has been a tough year. The pandemic posed an array of challenges to the healthcare system and the global biopharmaceutical industry both rose to the challenges and seized opportunities.
FDA Orange Book 101 Lin Zhang
February 04, 2021
There are thousands of drugs out there, each with specific benefits, potential side effects, and possible interactions, with many of the drugs being equivalent to one another or serving as alternative treatments for the same issue.
Chinese-Produced Anticancer Drugs Granted Designations by the FDA PharmaSources/Xiaobin
February 08, 2021
As we wave goodbye to 2020 and embrace the arrival of 2021, it’s time for us to review, sum-up, and outlook.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
Pharma and Health from Ingredients to Pills: What’s NEW on FDA Easy Labeling ? Lin Zhang
November 23, 2020
Medicine labeling is important and affects individual health on a daily basis, for patients, and the effectiveness of prescriptions for healthcare professionals.
FDA Generally Recognized As Safe (GRAS) 101 Lin Zhang
August 27, 2020
Generally recognized as safe (GRAS) (1) is the U.S. Food and Drug Administration (FDA) designation that a chemical or substance added to food is considered safe.
Old Drugs for New Indications Lin Zhang
June 01, 2020
Repurposing drugs is not new to the pharmaceutical industry. There are numerous effective therapeutic agents whose side effect profiles have been documented over long-term use in clinical settings that are potential candidates for repurposing.
Pharmaceutical News of the Week (July. 13th-July. 17th) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 22, 2020
With the third week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions, and miscellany that happened during July 13-17, including 30 pieces.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 365 366 Next page